The HR software provider has raised the stake issued in May 2015 through the $500m Comcast-backed round from 11% to 25% in the wake of a regulatory scandal.

The news roundup for the week ending 24 June 2016.

Abingdon Health enters into a partnership with Sumitomo Chemical to build on the rapid diagnostic test platform developed by Sumitomo and Abingdon Health subsidiary Molecular Vision.

Queensland, Sydney, RMIT, South Australia and Curtin universities agree to a standardised approach to IP to increase the country's current OECD ranking.

Imperial Innovations led the round, while Consort Medical also participated as it enters into a collaboration agreement with the retinal disease treatment developer.

Bath University spinout Atlas Genetics gains approval to sell its rapid chlamydia test within the EU.

The country is reportedly planning to let commercial banks create venture capital units to invest in technology startups.

The Securities and Exchange Commission (SEC) adopts crowdfunding rules after long wait.

Swansea spinout Bionema has received watchdog approval to test its biopesticides that could stop pests from destroying crops.